• Tidak ada hasil yang ditemukan

Supplemental Digital Content 1: GOLIGHER'S CLASSIFICATION

N/A
N/A
Protected

Academic year: 2024

Membagikan "Supplemental Digital Content 1: GOLIGHER'S CLASSIFICATION"

Copied!
5
0
0

Teks penuh

(1)

Supplemental Digital Content 1:GOLIGHERS CLASSIFICATION Grade Degree of prolapse

I No prolapse

II Prolapse on defecation with spontaneous reduction III Prolapse on defecation requiring manual reduction IV Prolapse and irreducible

(2)

Supplemental Digital Content 2:SODERGREN HEMORRHOID SYMPTOM SEVERITY SCORING SYSTEM

1) have you considered or excluded another pathology? Yes/No 2) Does the patient suffer from rectal bleeding? Yes/No

Only proceed with questionnaire if YES is the answer to both questions

Please answer the following questions relating to symptoms, at or around your anus.

Symptoms Points score How severe are your symptoms

of itching or irritation?

(circle number from 1-5)

0 1 2 3 4 5

No symptoms

Mild / do not really bother me Moderately bothersome Severe

0 0 0 0 4 4 How severe are your symptoms

of pain or discomfort at rest?

(circle number from 1-5)

0 1 2 3 4 5

No symptoms

Mild / do not really bother m Moderately bothersome Severe

0 0 0 3 3 3 How severe are your symptoms

of pain or discomfort on opening your bowels?

(circle number from 1-5)

0 1 2 3 4 5

No symptoms

Mild / do not really bother me Moderately bothersome Severe

0 0 0 0 3 3 How often do you feel that you

might have a lump at your anus (prolapse)?

0 1 2 3 4

Never

Less than once a month More than once a month More than once a week Every day

0 0 0 0 4

Final score (0 – 14 points)

(3)

Supplemental Digital Content 3:HEMORRHOIDAL DISEASE BLEEDING GRADE

Type of bleeding Grade

No rectal bleeding 0

Bleeding when passing stool less than once a week 1

Bleeding when passing stool 1–6 days per week 2

Bleeding when passing stool every day or with hemodynamic/laboratorial changes

(anemia, with or without transfusion need, signs of hypovolemia) 3

(4)

Participants not achieving therapeutic success

n=13

Polidocanol foam group

n=4 Rubber band ligation group

n=9

Therapeutic failure

n=4

Moderate/Severe complications

n=0

Therapeutic failure

n=7

Moderate/Severe complications

n=2

Rubber band ligation

n=3

Hemorrhoidal Artery Ligation

n=1

Polidocanol foam sclerotherapy

n=7

Milligan-Morgan hemorrhoidectomy

n=2

(5)

SUPPLEMENTAL DIGITAL CONTENT 5:RECURRENCE COMPARISON BETWEEN TREATMENT GROUPS

All

Polidocanol foam

Rubber band

ligation p Recurrence 3 months (n=107) (n=56) (n=51)

0.184 None: n (%) 104 (97.2) 56 (100.0) 48 (94.1)

Severe: n (%) 2 (1.87) 0 (0.00) 2 (3.92) Deceased: n (%) 1 (0.93) 0 (0.00) 1 (1.96) Recurrence 6 months (n=104) (n=56) (n=48)

0.088 None: n (%) 100 (96.2) 56 (100.0) 44 (91.7)

Mild: n (%) 2 (1.92) 0 (0.00) 2 (4.17) Severe: n (%) 2 (1.92) 0 (0.00) 2 (4.17) Recurrence 9 months (n=100) (n=56) (n=44)

0.357 None: n (%) 88 (88.0) 51 (91.1) 37 (84.1)

Mild: n (%) 10 (10.0) 4 (7.14) 6 (13.6) Severe: n (%) 1 (1.00) 0 (0.00) 1 (2.27) Deceased: n (%) 1 (1.00) 1 (1.79) 0 (0.00) Recurrence 12 months (n=88) (n=51) (n=37)

0.123 None: n (%) 75 (85.2) 46 (90.2) 29 (78.4)

Mild: n (%) 13 (14.8) 5 (9.80) 8 (21.6)

Tests used to compare variables between groups: Chi-square test (Recurrence).

Referensi

Dokumen terkait

4 eAppendix 4: WinBUGS models a Variable definitions: Variable Definition f_totaliq Total IQ score from WPPSI-III dNumAsc2T Dummy variable for being infected with Ascaris

An intensive pharmacokinetic substudy collected plasma samples over a 24-h period at steady state in a subset of patients enrolled in selected sites at Week 4; the maximum observed

4 The PP analysis set was a subset of the ITT analysis set, and consisted of subjects who completed all 5 scheduled visits without major protocol deviations or violations.. 6

Fit Statistics for Multinomial Probit Model Statistic Value Number of observations 141,851 Wald Chi-square p-value 55471.43 p... *Reference group is the combined Some Moderate

Sensitivity analyses of coxibs versus relatively selective COX-2 inhibitors according to sample size and study quality.. Study Participant RR95%CI Ulcer complications Sample size

NeuroRehabilitation 2014;35:825 Rats, S-D, adult male, 120 min MCAO Treatment Propofol 10 mg.kg- 1.h-1, dexmedetomidine 4 μg.kg-1.h-1 intravenously alone All groups received

Forest plot of individual and pooled estimates of sensitivity and specificity for the correlation of CICFA results with risk of infections in the liver transplantation group.. The point

7 + Table 2 Study risk of bias assessment 11 Specify the methods used to assess risk of bias in the included studies, including details of the tools used, how many reviewers N/A...